Essay About Pgp08065 And Analysis Of Results Of Period

Markstrat Simulation for Relive
Essay Preview: Markstrat Simulation for Relive
Report this essay
Final Review – Markstrat Simulation[pic 1]Submitted to – Prof. Bhalender S. NayyarSubmitted by:     Relive (Team R – Italy)Vineet Kumar (PGP08065)Sumit Kumar (PGP08125)Rohit Garg (PGP08113)Atul Chakrawarty (PGP08078)                                                                Bhaskar Haldar (PGP08081)Executive SummaryThis report covers the analysis of results of Period 6 to period 10 of Markstrat Simulation for Relive. This is being done by analyzing the KPIs to see the increase or decrease in key parameters. It covers expenses incurred and revenue earned through sales of products. Further analysis is done based on different segment groups in market and our products present in those segments. Along with this we have done competitors analysis by considering consumer panel, distribution panel and competitive advertising, commercial/merchandising decisions and growth share matrix. As we had modified and launched new products we have explained it in our R and D implementation and planning strategy. We have dissected characteristics of each of the brand available and its performance throughout 6 to 10 period. This primarily is a situation analysis of the end periods.ContentsSegment Analysis        5Round 6        6Round 7        7Round 8        8Round 9        9Round 10        10KPI AnalysisPeriod 6Period 7Period 8Period 9Period 10Revenues2,37,7842,36,6062,48,3322,86,2673,26,984Cost of goods sold-92,961-98,842-1,15,454-1,18,508-1,24,582Inventory holding costs-4,691-2,552-2,074-1,370-1,579Inventory selling costs-6730-54600Contribution before marketing1,39,4591,35,2111,30,2581,66,3902,00,823Advertising media-10,490-9,227-8,453-9,579-9,679Advertising research-720-260-530-390-300Commercial team costs-12,268-11,741-15,386-14,723-14,958Contribution after marketing1,15,9811,13,9841,05,8891,41,6981,75,886Market research studies-422-423-431-608-863Research and development0-3,150000Loan reimbursed00000Loan received00000Interests paid00000Exceptional costs or profits-2,10000-1,6070Earnings before taxes1,13,4591,10,4111,05,4581,39,4841,75,023`Till 10th round we had 4 products available in the clinite market and 3 products in Nutrite market. We had segmented our products for singles, low income, middle income and high earners for Nutrite and Health conscious, Family and Elderly for Clinites. Each of them particularly targeted only its respective segment. Our sales has been consistently increasing with few hiccups face in middle rounds.PeriodFirmShare Price IndexRevenuesNet contributionMarket share – ValueRetail salesMarket share – UnitVolume sold10R4,4623,26,9841,75,02319.1%5,00,95117.9%32,7249R3,9922,86,2671,39,48420.2%4,41,01916.9%26,3038R3,5832,48,3321,05,45821.3%3,84,05517.2%23,5657R3,5452,36,6061,10,41123.1%3,68,41418.8%23,2836R3,4182,37,7841,13,45923.8%3,72,53618.9%21,905[pic 2]Our SPI has been increasing uniformly although we are way short of what we expected to be in market share by 10th round. Each of the KPI has seen a significant increase other than market share compared to previous round. In the fifth round due to our wrong positioning of product Rich we had a significant amount of inventory leading to decrease in unit market share. We moved further from setback faced in fifth round to a significant growth in final rounds.